CeriBell Quarterly Cash Flow Statement
NASDAQ: CBLLHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CeriBell free cash flow
In the quarter ended Jun 30, 2026, CeriBell generated -$12.9 million of operating cash flow and spent $17,000 on capital expenditures. That left free cash flow of -$12.9 million, a free-cash-flow margin of -45.8% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
CeriBell cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -19.27M | -19.74M | -13.53M | -13.46M | -13.64M | -12.78M | -12.58M | -10.42M | -8.94M | -8.52M | -8.27M | -7.05M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 245.00K | 239.00K | 291.00K | 391.00K | 324.00K | 335.00K | 364.00K | 243.00K | 277.00K | 257.00K | 233.00K | 173.00K |
| Stock-Based Compensation | 6.00M | 3.72M | 3.36M | 3.35M | 3.17M | 2.35M | 2.20M | 1.38M | 1.08M | 757.00K | 745.00K | 637.00K |
| Change in Working Capital | 290.00K | -1.12M | -3.58M | -1.07M | 1.39M | 796.00K | -2.83M | -1.87M | 82.00K | -368.00K | -1.61M | — |
| Operating Cash Flow | -12.86M | -19.30M | -10.77M | -11.10M | -7.53M | -11.40M | -9.97M | -8.54M | -6.98M | -9.55M | -6.67M | — |
| Capital Expenditures | -17.00K | -125.00K | -179.00K | -369.00K | -71.00K | -148.00K | -357.00K | -567.00K | -321.00K | -95.00K | -477.00K | — |
| Investing Cash Flow | -606.00K | 22.44M | 26.11M | -6.94M | -107.69M | -29.61M | -493.00K | 183.00K | -1.16M | -132.00K | -683.00K | — |
| Debt Issued | — | — | 0 | 0 | — | — | 0 | 0 | 0 | 7.91M | — | — |
| Financing Cash Flow | 880.00K | 1.63M | 1.40M | 1.64M | 2.01M | 2.00K | 190.73M | -1.89M | -2.00K | 7.68M | -3.46M | — |
| Net Change in Cash | -12.59M | 4.78M | 16.74M | -16.40M | -113.22M | -41.01M | 180.26M | -10.25M | -8.13M | -2.00M | -10.82M | — |
| Free Cash Flow | -12.88M | -19.42M | -10.95M | -11.47M | -7.60M | -11.55M | -10.33M | -9.11M | -7.30M | -9.64M | -7.15M | — |
This table shows 12 quarterly periods of CeriBell's cash flow statement, from Q2 2026 back to Q3 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CBLL's reporting calendar. What is a cash flow statement?